	Diagnostic Performance of (68)Ga-FAPI PET/CT Versus (18)F-FDG PET/CT in Evaluating Neoadjuvant Therapy Pathological Response in Breast Cancer. NPJ Breast Cancer Zhu S, Jin Y, Hu C, Fan Y, Fei X, Hu J, Chen X. PMID: 42230653 [PubMed - as supplied by publisher]
	Predictive Features Specific to FIGO IIIA1 Ovarian Cancer: What Drives Prognosis. Ann Surg Oncol Bruno M, Arrigo D, Paratore M, Lopopolo G, Gallotta V, Rosati A, D'Indinosante M, Fagotti A. PMID: 42230470 [PubMed - as supplied by publisher]
	Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer. Ann Oncol Francis PA, Pagani O, Fleming GF, Walley BA, Colleoni M, Rubovszky G, Tondini C, Ciruelos EM, Gomez HL, Bonnefoi HR, Burstein HJ, Chini C, Puglisi F, Spazzapan S, Bernardo A, Climent MA, Bellet M, Ruhstaller T, Bermejo B, Chia SKL, Martino S, Geyer CE Jr, Goetz MP, Ingle JN, Stearns V, Davidson NE, Le Du F, Müller B, Coleman RE, Loibl S, Winer EP, Ruepp B, Loi S, Láng I, Coates AS, Gelber RD, Goldhirsch A, Regan MM, International Breast Cancer Study Group, SOFT and TEXT Investigators. PMID: 42229584 [PubMed - as supplied by publisher]
	Impact of adjuvant breast radiotherapy on the risk and the survival of second primary lung cancer: a large population-based study. Jpn J Clin Oncol Ji NN, Yang XY, Xiao SQ, Zhao N, Su WL, Xu JN, Shao L, Li SN, Zeng YC. PMID: 42228854 [PubMed - as supplied by publisher]
	Evaluating the Performance of Large Language Models for Breast Cancer Patient Education: A Comparative Study. J Cancer Educ Zhang Q, Yu Q, Wang G, Zeng Z, Liu S, Rao X, Cheng C, Wang X, Shi L, Wang S, He S, Wang Y. PMID: 42228312 [PubMed - as supplied by publisher]
	The role of cellular senescence in immune-metabolic features and prognosis of ovarian cancer: an integrated analysis based on single-cell sequencing and multi-omics data. Geroscience Li Y, Bai M, Zhou Z, Wu W, Wu H, Ling S, Wang L, Zheng Y. PMID: 42228240 [PubMed - as supplied by publisher]
	Pretreatment neutrophil-to-lymphocyte ratio (NLR) as a potential risk marker for febrile neutropenia (FN) in breast and ovarian cancer during first-cycle chemotherapy. Support Care Cancer Saif F, Qureshi FN, Ahmad A, Durrani F, Azam NUA, Ullah I, Ahmed ZUD, Khan AR. PMID: 42228187 [PubMed - in process]
	Photobiomodulation for hormone therapy-induced sexual dysfunction in women with breast cancer: a prospective quasi-experimental clinical study with a parallel observational group. Support Care Cancer Vieira LR, Rezende LF. PMID: 42228167 [PubMed - in process]
	Real-World Study on the Efficacy and Safety of Incadronate Disodium in Treating Bone Metastases of Advanced Breast Cancer. Curr Pharm Des Zhu A, Gui X, Zhang R, Liang X, Shao B, Di L, Song G. PMID: 42227384 [PubMed - as supplied by publisher]
	Denosumab versus bisphosphonates for the management of bone metastases originating from breast cancer: a systematic review and meta-analysis. Future Oncol Boutros M, Awad G, Saad JP, Mitri M, Masrouha K. PMID: 42227119 [PubMed - as supplied by publisher]
	Postoperative Complications Following Neoadjuvant Therapy Across Different Oncoplastic Breast Surgery Techniques: A Retrospective Comparative Study in Breast Cancer Patients. Breast Cancer (Dove Med Press) Kulturoglu MO, Dogan L, Gulcelik MA. PMID: 42226889 [PubMed]
	Ferroptosis in breast cancer: From adipocyte-immune-iron regulation to therapeutic application. Clin Transl Med Sun J, Qu Y, Yao R, Zhou Y. PMID: 42226605 [PubMed - indexed for MEDLINE]
	Identification of Key Microbial Signatures Associated With Breast Cancer: Machine Learning-Based Approaches Using Gut Microbiome Data. Cancer Med Ahmed MT, Majumdar S, Noman AA, Alam MJ, Alam MJ. PMID: 42226580 [PubMed - in process]
	Breast cancer survival prediction using machine learning and multimodal data for personalized care plan. BMC Cancer Rady Raz N, Nafissi N, Babaee E, Fadavi P. PMID: 42226239 [PubMed - as supplied by publisher]
	Antibody-drug conjugates in breast cancer. Cancer Sakach EA, Meisel JL, McArthur HL. PMID: 42225999 [PubMed - in process]
	WeCare intervention to improve breast cancer screening and research preparedness in rural and low-socioeconomic women: study protocol for a community-engaged feasibility trial. BMJ Open Sharma P, Imsande KG, Vitriago A, Seibel M, Pritchett JC, Rudder B, Watson D, Beenken MJ, Tran LT, Larson SL, Flock C, Murphy CM, Puljas TL, Patten CA, Asiedu GB, Odedina FT, Lynch BA, Haddad TC. PMID: 42225362 [PubMed - in process]
	CRI-CCTG-0003/IND.240 an immunotherapy platform study in platinum-resistant high grade serous ovarian cancer (IPROC): Sub-studies A and B: Durvalumab (D) + mecbotamab vedotin (BA3011) or ozuriftamab vedotin (BA3021). Cancer Treat Res Commun MacKay HJ, Tinker AV, Nelson BH, Zamarin D, Odunsi AO, Lheureux S, Ellard S, Smrke A, Gaudreau PO, Faulkner T, Upadhaya S, Zhou A, Tu W, Dancey J. PMID: 42225005 [PubMed - as supplied by publisher]
	Targeting tryptophan metabolism in breast cancer immunotherapy: Recent advances and future prospects. Transl Oncol Li G, Zhou H, Shen X, Ying P, Lu H. PMID: 42224955 [PubMed - as supplied by publisher]
	The effects of a financial navigation intervention on financial toxicity among patients with breast cancer in China: A randomized controlled trial. Breast Jing F, Yuan X, Tang Y, Liu Y, Huang Y, Chen L, Tang L, Qiu J, Xing W. PMID: 42224905 [PubMed - as supplied by publisher]
	Feasibility and Preliminary Effectiveness of the ChulaCancer Mobile Chatbot for Supportive Care of Patients With Breast or Colorectal Cancer Receiving Chemotherapy: Pilot Randomized Controlled Trial. JMIR Form Res Sompornpailin N, Susiriwatananont T, Sriuranpong V, Tanasanvimon S, Vinayanuwattikun C, Sitthideatphaiboon P, Poovorawan N, Teeyapun N, Zungsontiporn N, Pakvisal N, Panjasriprakarn P, Trakarnsanga B, Parinyanitikul N. PMID: 42224667 [PubMed - in process]

Articles 1 - 20 / 329585

Page 1 of 16480



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy